Related references
Note: Only part of the references are listed.Survival of patients with Kaposi's sarcoma in the South African antiretroviral treatment era: A retrospective cohort study
M. M. Sengayi et al.
SAMJ SOUTH AFRICAN MEDICAL JOURNAL (2017)
Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study
Raul U. Hernandez-Ramirez et al.
LANCET HIV (2017)
Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea
Cavin E. Bekolo et al.
BMC CANCER (2017)
Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi
Michael E. Herce et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2015)
A contribution for a more accurate estimation of the incidence of Kaposi sarcoma in Mozambique
Carla Carrilho et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Clinical Activity of Lenalidomide in Visceral Human Immunodeficiency Virus-Related Kaposi Sarcoma
Maud Steff et al.
JAMA DERMATOLOGY (2013)
Paradoxical Immune Reconstitution Inflammatory Syndrome in HIV-Infected Patients Treated With Combination Antiretroviral Therapy After AIDS-Defining Opportunistic Infection
Chad J. Achenbach et al.
CLINICAL INFECTIOUS DISEASES (2012)
A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa
Anisa Mosam et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Comparison of safety and toxicity of liposomal doxorubicin vs. conventional anthracyclines: a meta-analysis
Shamudheen M. Rafiyath et al.
EXPERIMENTAL HEMATOLGY & ONCOLOGY (2012)
The Increasing Burden of HIV-Associated Malignancies in Resource-Limited Regions
Corey Casper
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Update on KSHV epidemiology, Kaposi Sarcoma pathogenesis, and treatment of Kaposi Sarcoma
Thomas S. Uldrick et al.
CANCER LETTERS (2011)
Treatment strategies for Kaposi sarcoma in sub-Saharan Africa: challenges and opportunities
Susan E. Krown
CURRENT OPINION IN ONCOLOGY (2011)
Expansion of cancer care and control in countries of low and middle income: a call to action
Paul Farmer et al.
LANCET (2010)
Can We Treat Cancer for a Dollar a Day? Guidelines for Low-Income Countries
David J. Kerr et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa
Kathryn M. Chu et al.
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY (2010)
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era
Emmanuelle Boffi El Amari et al.
AIDS (2009)
AIDS-Related Kaposi's Sarcoma: State of the Art and Therapeutic Strategies
Ferdinando Martellotta et al.
CURRENT HIV RESEARCH (2009)
Part II: Cancer in indigenous Africans - causes and control
Freddy Sitas et al.
LANCET ONCOLOGY (2008)
Management of AIDS-related Kaposi's sarcoma
Giuseppe Di Lorenzo et al.
LANCET ONCOLOGY (2007)
Pegylated liposomal doxorubicin plus highly active antiretroviral therapy versus highly active antiretroviral therapy alone in HIV patients with Kaposi's sarcoma
L Martín-Carbonero et al.
AIDS (2004)
Effect of treatment on health-related quality of life in acquired immunodeficiency syndrome (AIDS)-related Kaposi's sarcoma: A randomized trial of pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine
D Osoba et al.
CANCER INVESTIGATION (2001)
Share Paper
